SFI
HBIO icon

Susquehanna Fundamental Investments’s Harvard Bioscience HBIO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$302K Sell
4,870
-1,749
-26% -$103K 0.01% 1264
2021
Q4 		$467K Sell
6,619
-1,180
-15% -$83.9K 0.01% 942
2021
Q3 		$544K Buy
7,799
+3,009
+63% +$239K 0.01% 1161
2021
Q2 		$399K Buy
+4,790
New +$339K 0.01% 1251

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna Fundamental Investments's HBIO Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Harvard Bioscience (HBIO) stake by 26% in Q1 2022, selling an estimated $103K and leaving 4,870 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #1264.

Susquehanna Fundamental Investments first reported a position in HBIO in Q2 2021 and has held it in 4 quarters since. The position peaked at $544K in Q3 2021. 98 funds tracked by Wall St. Rank hold HBIO as of Q1 2022.

  • Susquehanna Fundamental Investments held 4,870 shares of Harvard Bioscience worth $302K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 1,749 Harvard Bioscience shares in Q1 2022, an estimated $103K.
  • Harvard Bioscience made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1264 holding.
  • Susquehanna Fundamental Investments first reported a position in Harvard Bioscience in Q2 2021 and has held it in 4 quarters since.
  • Susquehanna Fundamental Investments's Harvard Bioscience position peaked at $544K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.